697368 |
NEURO-ONCOLOGY |
ATRT-09. IDENTIFICATION OF POTENTIAL GENETIC DRIVERS OF METHOTREXATE (MTX) RESISTANCE IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) THROUGH A GENOME-WIDE RNAI SCREEN |
2021-06-01 |
10.1093/neuonc/noab090.008 |
Kannappan Sunand, Gupa Mehul, Kang SungMyung, Tran Andy Son, Thakur Satbir Singh, Jain Mohit, Narendran Aru |
697367 |
NEURO-ONCOLOGY |
HGG-17. FOCUSED ULTRASOUND-ENHANCED DELIVERY OF RADIOLABELED AGENTS TO DIFFUSE INTRINSIC PONTINE GLIOMA |
2021-06-01 |
10.1093/neuonc/noab090.083 |
Ye Dezhuang, Zhang Xiaohui, Yang Lihua, Yue Yimei, Tai Yuan-chuan, Rubin Joshua B, Liu Yongjian, Chen Hong |
697366 |
NEURO-ONCOLOGY |
HGG-26. SINGLE-CELL RNA-SEQ OF PEDIATRIC HIGH-GRADE GLIOMAS IDENTIFIES COMMON ONCOGENIC PROCESSES AMONG DISTINCT TUMOR HISTOLOGIES |
2021-06-01 |
10.1093/neuonc/noab090.090 |
DeSisto John, Donson Andrew, Fu Rui, Sanford Bridget, Riemondy Kent, Green Adam |
697365 |
NEURO-ONCOLOGY |
ATRT-01. IDENTIFICATION OF MICRORNA-BASED PROGNOSTIC BIOMARKERS AND CANDIDATE THERAPEUTIC AGENTS FOR ATYPICAL TERATOID/RHABDOID TUMOR |
2021-06-01 |
10.1093/neuonc/noab090.001 |
Zhang Yang |
697364 |
NEURO-ONCOLOGY |
RARE-22. THERAPEUTIC TARGETING OF PURINE METABOLISM IN DIPG |
2021-06-01 |
10.1093/neuonc/noab090.183 |
Mersich Ian, Dasgupta Biplab |
697363 |
NEURO-ONCOLOGY |
BIOL-06. MIR-1253 POTENTIATES CISPLATIN RESPONSE IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA BY REGULATING FERROPTOSIS |
2021-06-01 |
10.1093/neuonc/noab090.013 |
Kanchan Ranjana, Khan Parvez, Perumal Naveenkumar, Atri Pranita, Venkata Ramakanth Chirravuri, Thapa Ishwor, Doss David, Nasser Mohd Wasim, Batra Surinder, Mahapatra Sidhartha |
697362 |
NEURO-ONCOLOGY |
LGG-07. IS BRAF ALTERATION OR A HISTOLOGIC ‘QUALIFIER’ A PREDICTOR OF OUTCOME IN PEDIATRIC PILOCYTIC ASTROCYTOMA? |
2021-06-01 |
10.1093/neuonc/noab090.131 |
Cler Samuel J, Skidmore Alexander, Yahanda Alexander T, Mian Ali, Mackey Kimberly, Dahiya Sonika, Strahle Jennifer |
697361 |
NEURO-ONCOLOGY |
HGG-35. IDENTIFICATION OF G PROTEIN-COUPLED RECEPTOR 17 (GPR17) UP-REGULATION IN PAEDIATRIC H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA AND EXAMINATION OF ITS ROLE IN DIFFUSE MIDLINE GLIOMA CELL LINES |
2021-06-01 |
10.1093/neuonc/noab090.099 |
Loveson Katie, Fillmore Helen |
697360 |
NEURO-ONCOLOGY |
HGG-02. NEUROPHYSIOLOGICAL SMALL MOLECULE SCREEN TO TARGET NEURON-GLIOMA INTERACTIONS IN PEDIATRIC HIGH-GRADE GLIOMAS |
2021-06-01 |
10.1093/neuonc/noab090.068 |
Rogawski David, Mulinyawe Sara, Thomas Craig, Monje Michelle |
697359 |
NEURO-ONCOLOGY |
EMBR-24. YB1 IS CRITICAL FOR MEDULLOBLASTOMA TUMOR MAINTENANCE AND DNA REPAIR FOLLOWING THERAPEUTIC INTERVENTION |
2021-06-01 |
10.1093/neuonc/noab090.042 |
McSwain Leon, Kenney Anna, Chen Victor, Huang Tiffany |